- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 5 residues within 4Å:- Chain A: N.243, S.245, A.250, N.251, F.269
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:S.245, A:S.245
NAG-NAG-BMA.4: 5 residues within 4Å:- Chain B: N.243, S.245, A.250, N.251, F.269
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:S.245, B:S.245
NAG-NAG-BMA.6: 5 residues within 4Å:- Chain C: N.243, S.245, A.250, N.251, F.269
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:S.245, C:S.245
- 42 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.7: 2 residues within 4Å:- Chain A: Y.96, N.98
Ligand excluded by PLIPNAG.8: 4 residues within 4Å:- Chain A: N.55, N.122, T.227, C.230
Ligand excluded by PLIPNAG.9: 3 residues within 4Å:- Chain A: Y.144, N.171, S.180
Ligand excluded by PLIPNAG.10: 5 residues within 4Å:- Chain A: F.90, T.131, L.133, N.218, N.220
Ligand excluded by PLIPNAG.11: 4 residues within 4Å:- Chain A: Y.305, D.307, N.326, I.327
Ligand excluded by PLIPNAG.12: 1 residues within 4Å:- Chain A: N.518
Ligand excluded by PLIPNAG.13: 2 residues within 4Å:- Chain A: V.288, N.440
Ligand excluded by PLIPNAG.14: 3 residues within 4Å:- Chain A: N.663, S.665, L.679
Ligand excluded by PLIPNAG.15: 1 residues within 4Å:- Chain A: N.542
Ligand excluded by PLIPNAG.16: 1 residues within 4Å:- Chain A: N.568
Ligand excluded by PLIPNAG.17: 2 residues within 4Å:- Chain A: N.581, D.959
Ligand excluded by PLIPNAG.18: 1 residues within 4Å:- Chain A: N.587
Ligand excluded by PLIPNAG.19: 1 residues within 4Å:- Chain A: N.671
Ligand excluded by PLIPNAG.20: 1 residues within 4Å:- Chain A: N.1015
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain B: Y.96, N.98
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain B: N.55, N.122, T.227, C.230
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain B: Y.144, N.171, S.180
Ligand excluded by PLIPNAG.24: 6 residues within 4Å:- Chain B: F.90, R.129, T.131, L.133, N.218, N.220
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain B: Y.305, D.307, N.326, I.327
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain B: N.518
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain B: V.288, I.290, N.440
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain B: N.663, S.665, L.679
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain B: N.542
Ligand excluded by PLIPNAG.30: 1 residues within 4Å:- Chain B: N.568
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: N.581, D.959
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain B: N.587
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain B: N.671
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain B: N.1015, T.1017, F.1018
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain C: Y.96, N.98
Ligand excluded by PLIPNAG.36: 5 residues within 4Å:- Chain C: N.55, N.56, N.122, T.227, C.230
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain C: Y.144, N.171, S.180
Ligand excluded by PLIPNAG.38: 5 residues within 4Å:- Chain C: F.90, T.131, L.133, N.218, N.220
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain C: Y.305, D.307, N.326, I.327
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain C: N.518
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain C: V.288, I.290, N.440
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain C: N.663, S.665, L.679
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain C: N.542
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain C: N.568
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain C: N.581, D.959
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain C: N.587
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain C: N.671
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain C: N.1015, F.1018
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Song, X. et al., Cryo-EM analysis of the HCoV-229E spike glycoprotein reveals dynamic prefusion conformational changes. Nat Commun (2021)
- Release Date
- 2020-12-23
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 42 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Song, X. et al., Cryo-EM analysis of the HCoV-229E spike glycoprotein reveals dynamic prefusion conformational changes. Nat Commun (2021)
- Release Date
- 2020-12-23
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C